ECKERT & ZIEGLER STRAHLEN- UND MEDIZINTECHNIK AG (FRA:EUZ) EQS-Adhoc: Eckert & Ziegler Again Increases Sales and Earnings in the First Nine Months Compared to Previous Year
Transparency directive : regulatory news
|
EQS-Ad-hoc: Eckert & Ziegler SE / Key word(s): 9 Month figures/Preliminary Results 3rd quarter of 2024:
First 9 months of 2024:
Forecast for 2024:
Berlin, 15 October 2024. According to preliminary calculations, Eckert & Ziegler SE (ISIN DE0005659700, TecDAX) generated sales of EUR 215.5 million in the first nine months of 2024 (previous year: EUR 183.9 million). The key figure EBIT before special items, introduced as part of the 2024 forecast, amounted to EUR 46.7 million in the first nine months of 2024 (previous year: EUR 37.7 million). Net profit, which is only reported here on a comparative basis, increased to EUR 23.4 million (previous year: EUR 20.3 million). The forecast for the 2024 financial year published on July 16, 2024, remains confirmed. The Executive Board continues to expect sales of just under EUR 265 million and EBIT before special items of around EUR 55 million. The full figures for the first nine months of 2024 will be published on November 14, 2024.
End of Inside Information
15-Oct-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Eckert & Ziegler SE |
| Robert-Rössle-Str.10 | |
| 13125 Berlin | |
| Germany | |
| Phone: | +49 30 941084-138 |
| Fax: | +49 30 941084-0 |
| Internet: | www.ezag.de |
| ISIN: | DE0005659700 |
| WKN: | 565970 |
| Indices: | SDAX, TecDax, |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2008981 |
| End of Announcement | EQS News Service |
|
|
2008981 15-Oct-2024 CET/CEST
source : webdisclosure.com